These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 20653799

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF, Wertz DA, Yang GW, Kamat S, Borok GM, Gandhi S, McDonough KL, Willey VJ.
    Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Populations in the United Kingdom.
    Cao X, Ejzykowicz F, Ramey DR, Sajjan S, Ambegaonkar BM, Mavros P, Tunceli K.
    Clin Ther; 2015 Apr 01; 37(4):804-15. PubMed ID: 25626487
    [Abstract] [Full Text] [Related]

  • 30. Begin with the real-world patients of non-goal-achieved hypercholesterolemia in taiwan through the ezetimibe/simvastatin tablet - The BRAVO Study.
    Huang JC, Lee TY, Liou MJ, Lin CM, Pei D, Chen ZC, Liu RT, Kwok CF.
    Curr Med Res Opin; 2011 Aug 01; 27(8):1645-51. PubMed ID: 21699369
    [Abstract] [Full Text] [Related]

  • 31. Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients.
    Miller AE, Hansen LB, Saseen JJ.
    Pharmacotherapy; 2008 May 01; 28(5):553-61. PubMed ID: 18447653
    [Abstract] [Full Text] [Related]

  • 32. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL, Cox ER.
    Am J Manag Care; 2008 Dec 01; 14(12):813-8. PubMed ID: 19067498
    [Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness of rosuvastatin versus ezetimibe/simvastatin in managing dyslipidemic patients in Mexico.
    Briseño GG, Mino-León D.
    Curr Med Res Opin; 2010 May 01; 26(5):1075-81. PubMed ID: 20225991
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 01; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 36. A comparative economic analysis of simvastatin versus atorvastatin: results of the Surrogate Marker Cost-Efficacy (SMaC) study.
    Badia X, Russo P, Attanasio E.
    Clin Ther; 1999 Oct 01; 21(10):1788-96. PubMed ID: 10566573
    [Abstract] [Full Text] [Related]

  • 37. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I.
    Kardiol Pol; 2004 Jun 01; 60(6):567-77. PubMed ID: 15334157
    [Abstract] [Full Text] [Related]

  • 38. The need for a systematic approach to statin switching: an analysis of real-world experience.
    Kakavas PW, McManus JL, Wolfe TA, Guidry T, Flores DN, Ter Riet LB, Glover JJ, Sell H.
    J Cardiovasc Nurs; 2013 Jun 01; 28(6):565-72. PubMed ID: 23064180
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
    Brown WV, Bays HE, Hassman DR, McKenney J, Chitra R, Hutchinson H, Miller E, Rosuvastatin Study Group.
    Am Heart J; 2002 Dec 01; 144(6):1036-43. PubMed ID: 12486428
    [Abstract] [Full Text] [Related]

  • 40. Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study.
    Van Ganse E, Laforest L, Alemao E, Davies G, Gutkin S, Yin D.
    Curr Med Res Opin; 2005 Sep 01; 21(9):1389-99. PubMed ID: 16197657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.